Melanocyte loss dominates the vitiligo transcriptome: a rank-based meta-analysis.

Area of Science:

• Dermatology
• Immunology
• Genomics

Background:

• Vitiligo is an autoimmune disorder resulting in melanocyte destruction.
• Understanding the molecular signatures of vitiligo skin is crucial for developing targeted therapies.

Purpose of the Study:

• To identify consensus gene expression signatures in vitiligo lesional skin.
• To characterize the molecular changes associated with melanocyte loss and immune activation in vitiligo.

Main Methods:

• A rank-based meta-analysis of six independent transcriptomic studies (microarray, bulk, and single-cell RNA-seq).
• Utilized Robust Rank Aggregation to identify differentially expressed genes.
• Pathway-level meta-analysis and single-cell data analysis were performed.

Main Results:

• Identified 114 differentially expressed genes (108 downregulated, 6 upregulated).
• Downregulated genes were predominantly melanocyte markers, indicating significant melanocyte loss.
• Upregulated genes included interferon-stimulated genes, suggesting immune activation, which was heterogeneous across datasets.
• Confirmed melanocyte depletion and identified novel candidate melanocyte markers (CYB561A3, QPCT).

Conclusions:

• Vitiligo exhibits a robust, platform-independent signature of melanocyte loss.
• Immune activation in vitiligo is present but shows study-dependent heterogeneity.
• Findings highlight the neural crest origin of melanocytes and identify potential therapeutic targets.